170 related articles for article (PubMed ID: 33600612)
1. Hypofractionated volumetric-modulated arc therapy for breast cancer: A propensity-score-weighted comparison of radiation-related toxicity.
Kim N; Chang JS; Shah C; Shin H; Keum KC; Suh CO; Kim YB
Int J Cancer; 2021 Jul; 149(1):149-157. PubMed ID: 33600612
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.
Fiorentino A; Gregucci F; Mazzola R; Figlia V; Ricchetti F; Sicignano G; Giajlevra N; Ruggieri R; Fersino S; Naccarato S; Massocco A; Corradini S; Alongi F
Radiol Med; 2019 Apr; 124(4):309-314. PubMed ID: 30547358
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F; Fogliata A; Franceschini D; Iftode C; Torrisi R; Masci G; Sagona A; Tinterri C; Testori A; Gatzemeier W; Fernandes B; Rahal D; Cozzi L; Santoro A; Scorsetti M
Br J Radiol; 2018 May; 91(1085):20170634. PubMed ID: 29322827
[TBL] [Abstract][Full Text] [Related]
5. Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients.
Iorio GC; Franco P; Gallio E; Martini S; Arcadipane F; Bartoncini S; Rondi N; Giglioli FR; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ricardi U
Med Oncol; 2017 Nov; 35(1):1. PubMed ID: 29209826
[TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation.
Osman SO; Hol S; Poortmans PM; Essers M
Radiother Oncol; 2014 Jul; 112(1):17-22. PubMed ID: 24825176
[TBL] [Abstract][Full Text] [Related]
7. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
[TBL] [Abstract][Full Text] [Related]
8. Assessment of acute toxicities and early local recurrences in post mastectomy breast cancer patients by accelerated hypofractionated radiotherapy; a single arm clinical trial.
Vijayaraghavan N; Vedasoundaram P; M Mathew J; Menon A; Kannan B
J BUON; 2020; 25(5):2265-2270. PubMed ID: 33277844
[TBL] [Abstract][Full Text] [Related]
9. Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
Dumane VA; Bakst R; Green S
PLoS One; 2018; 13(10):e0205770. PubMed ID: 30339705
[TBL] [Abstract][Full Text] [Related]
10. Modern Rotational Radiation Techniques with Volumetric Modulated Arc Therapy or Helical Tomotherapy for Optimal Sparing of the Lung and Heart in Left-Breast Cancer Radiotherapy Plus Regional Nodal Irradiation: A Comparative Dosimetric Analysis.
Hou PY; Hsieh CH; Wu LJ; Hsu CX; Kuo DY; Lu YF; Tien HJ; Hsiao HW; Shueng PW; Hsu SM
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680189
[TBL] [Abstract][Full Text] [Related]
11. Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities.
Doi Y; Nakao M; Miura H; Ozawa S; Kenjo M; Nagata Y
J Radiat Res; 2020 Sep; 61(5):747-754. PubMed ID: 32785596
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
[TBL] [Abstract][Full Text] [Related]
13. VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions.
La Rocca E; Lozza L; D' Ippolito E; Dispinzieri M; Giandini C; Bonfantini F; Valdagni R; Folli S; Pignoli E; Di Cosimo S; De Santis MC
Clin Transl Oncol; 2020 Oct; 22(10):1802-1808. PubMed ID: 32128672
[TBL] [Abstract][Full Text] [Related]
14. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
15. Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.
Vassis S; Nöldeke B; Christiansen H; von Klot CA; Merten R
Strahlenther Onkol; 2020 Jul; 196(7):598-607. PubMed ID: 32040691
[TBL] [Abstract][Full Text] [Related]
16. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
[TBL] [Abstract][Full Text] [Related]
17. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
De Rose F; Fogliata A; Franceschini D; Navarria P; Villa E; Iftode C; D'Agostino G; Cozzi L; Lobefalo F; Mancosu P; Tomatis S; Scorsetti M
Radiat Oncol; 2016 Sep; 11(1):120. PubMed ID: 27639373
[TBL] [Abstract][Full Text] [Related]
19. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
Alongi F; Cozzi L; Fogliata A; Iftode C; Comito T; Clivio A; Villa E; Lobefalo F; Navarria P; Reggiori G; Mancosu P; Clerici E; Tomatis S; Taverna G; Graziotti P; Scorsetti M
Anticancer Res; 2013 Oct; 33(10):4537-43. PubMed ID: 24123027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
